Sun Pharma Advanced Research Company Reports Mixed Financial Results for December Quarter

Feb 11 2025 10:35 AM IST
share
Share Via
Sun Pharma Advanced Research Company (SPARC) has released its financial results for the quarter ending December 2024, showcasing its highest quarterly operating profit in five quarters. Despite improvements in operational metrics, the company faces challenges, including a significant rise in interest costs and a decline in net sales year on year.
Sun Pharma Advanced Research Company (SPARC) has recently reported its financial results for the quarter ending December 2024, revealing a complex picture of its performance. The company has experienced a notable adjustment in its evaluation, with its score shifting to -12 from -28 over the past three months.

In terms of operational metrics, SPARC achieved its highest quarterly operating profit in the last five quarters, recorded at Rs -73.69 crore. This reflects a positive near-term trend in operating profit. Additionally, the operating profit margin reached its peak at -494.23%, indicating an improvement in the company's efficiency. Other key metrics, such as profit before tax and profit after tax, also showed their highest figures in the last five quarters, with values of Rs -79.63 crore and Rs -79.51 crore, respectively.

However, challenges remain evident. The company reported a significant rise in interest costs, which grew by 145.61% quarter on quarter, signaling increased borrowings. Furthermore, net sales for the half-yearly period declined by 20.75% year on year, indicating a negative trend in sales performance.

For more insights, Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News